Home › Stocks › ACRS › All Fund Holders
ACRS — ACLARIS THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 35 · Reported value held: $162.03M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 10.04M | $53.10M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 6.50M | $19.57M | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 3.19M | $16.88M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 2.39M | $12.63M | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 2.02M | $10.70M | 0.01% | Reduce |
| Janus Henderson Group history | Q4 2024 | 2.80M | $6.99M | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 1.04M | $5.51M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 998.76K | $5.28M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 817.53K | $4.32M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 609.16K | $3.22M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 523.89K | $2.77M | 0.00% | Reduce |
| Marshall Wace history | Q1 2026 | 712.98K | $2.67M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 468.96K | $2.35M | 0.00% | New |
| D. E. Shaw & Co history | Q2 2026 | 414.50K | $2.19M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 346.06K | $1.83M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 313.85K | $1.66M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 282.60K | $1.49M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 267.50K | $1.42M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 257.00K | $1.36M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 243.03K | $1.29M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 134.12K | $709.48K | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 133.07K | $703.93K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 117.79K | $623.09K | 0.00% | Add |
| Franklin Resources history | Q4 2021 | 41.99K | $611.00K | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 110.41K | $584.08K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 108.65K | $574.75K | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 60.26K | $318.77K | 0.00% | Reduce |
| Point72 Asset Management history | Q4 2025 | 87.17K | $262.40K | 0.00% | New |
| Manulife Financial history | Q2 2026 | 32.41K | $171.43K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 20.27K | $107.23K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 11.52K | $60.93K | 0.00% | Add |
| Amundi US history | Q1 2023 | 3.98K | $34.42K | 0.00% | Hold |
| Principal Global Investors history | Q1 2024 | 17.65K | $21.89K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 2.06K | $10.92K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 221.60K | $1.17K | 0.00% | Add |